Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic steroid injection versus systemic steroid in idiopathic sudden sensorineural hearing loss
TCTR20211018002Phase 4Unknown
- Sponsor
- N/A
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 4 trial in idiopathic sudden sensorineural hearing loss (ISSNHL) (2 arms), sponsored by N/A. Status: unknown.
02
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on TCTR20211018002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211018002.